Fasting Contraindications in Hypothalamic Amenorrhea
Introduction to Hypothalamic Amenorrhea and Fasting
- Fasting is contraindicated in women with functional hypothalamic amenorrhea (FHA), regardless of whether they have polycystic ovarian morphology (PCOM) features, as it would worsen the underlying energy deficit that causes FHA and potentially exacerbate health consequences 1
Diagnostic Criteria and Differentiation
- Up to 43% of women with FHA may have polycystic ovarian morphology (PCOM) or "PCO-like abnormalities" 2
- Despite PCOM features, the primary diagnosis remains FHA if there are clear signs of energy deficiency and estrogen deficiency 1
- LH:FSH ratio <1 is found in about 82% of FHA patients, while PCOS typically shows LH:FSH ratio >2 1
- Endometrial thickness is a good indicator of estrogen status; thin endometrium suggests FHA 1
- Presence of typical causes of FHA (excessive exercise, underweight, caloric deficiency, stress) alongside signs of estrogen deficiency strongly supports an FHA diagnosis 1
Management and Treatment
- The Endocrine Society guidelines emphasize that addressing energy deficit is crucial for FHA recovery 3
- The Endocrine Society recommends that women with FHA should have a BMI ≥18.5 kg/m² before considering ovulation induction 3
Long-term Health Considerations
- FHA is associated with bone health deterioration, with a 2-fold increased risk of fractures compared to healthy women 2
- Hormone replacement therapy (preferably transdermal estradiol with cyclic oral progestin) is recommended over combined oral contraceptives to protect bone health 2, 4
- Combined oral contraceptives inhibit IGF-1 production via first-pass hepatic metabolism, potentially decreasing osteoblastic activity 2
- Baseline bone mineral density measurement is recommended in those with at least 6 months of amenorrhea 2
Special Considerations for FHA-PCOM
- Despite PCOM features, the primary treatment approach should still address the energy deficit 1
- Studies show that after recovery from FHA, many women with PCOM features see decreases in AMH, androgens, and ovarian volume 2
- Only a small percentage of women with FHA-PCOM develop true PCOS after recovery 2